BioCentury
ARTICLE | Company News

Prosonix, Imperial College, King's College, Medical Research Council, University of Bath inflammation, pulmonary, drug delivery news

January 14, 2013 8:00 AM UTC

Prosonix received a grant worth up to £1.3 million ($2.1 million) from the U.K.'s Biomedical Catalyst fund for preclinical development of inhaled combination treatments using Prosonix's multi-componen...